caprylates has been researched along with Cardiovascular Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 8 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, G; Batzella, E; Canova, C; Dalla Zuanna, T; Di Nisio, A; Fletcher, T; Pitter, G; Russo, F | 1 |
| Braun, JM; Buckley, JP; Cecil, KM; Chen, A; Eaton, CB; Kalkwarf, HJ; Kelsey, KT; Lanphear, BP; Li, N; Papandonatos, GD; Sears, CG; Yolton, K | 1 |
| Aylward, LL; Bräunig, J; Kay, M; King, L; Kirk, MD; Marrington, S; Mueller, JF; Nilsson, S; Smurthwaite, K; Toms, LM | 1 |
| Borenstein, AR; Dai, Q; Dugan, LL; Fan, L; Huang, X; Shrubsole, MJ; Zhu, X | 1 |
| Bucheit, JD; Carter, N; Dixon, DL; Malloy, K; Pamulapati, LG; Sisson, EM | 1 |
| Campello, E; Dall'Acqua, S; De Toni, L; Di Nisio, A; Foresta, C; Guidolin, D; Radu, CM; Sabovic, I; Simioni, P; Spampinato, S | 1 |
| Braun, JM; Calafat, AM; Cecil, KM; Chen, A; Eaton, CB; Kalkwarf, HJ; Kelsey, KT; Lanphear, BP; Li, N; Liu, Y; Papandonatos, GD; Yolton, K | 1 |
| Abd Latip, N; Abdul Rahman, A; Abdullah Soheimi, SS; Ibrahim, E; Sheikh Abdul Kadir, SH | 1 |
| Bartell, SM; Butler, RA; Fletcher, T; Kelsey, KT; Watkins, DJ; Wellenius, GA | 1 |
| Anderson-Mahoney, P; Dahlgren, J; Gray, D; Kotlerman, J; Takhar, H | 1 |
| Fletcher, T; Savitz, DA; Steenland, K | 1 |
| Ducatman, A; Shankar, A; Xiao, J | 1 |
| Mukherjee, D | 1 |
| Chapkynov, P; Kristev, A; Lukanov, Y; Mitkov, D | 1 |
3 review(s) available for caprylates and Cardiovascular Diseases
| Article | Year |
|---|---|
Oral Semaglutide: A Review of the First Oral Glucagon-Like Peptide 1 Receptor Agonist.
Topics: Administration, Oral; Caprylates; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Delivery Systems; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Renal Insufficiency, Chronic | 2020 |
Understanding the Impact of Perfluorinated Compounds on Cardiovascular Diseases and Their Risk Factors: A Meta-Analysis Study.
Topics: Alkanesulfonic Acids; Caprylates; Cardiovascular Diseases; Fluorocarbons; Humans | 2021 |
Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).
Topics: Caprylates; Cardiovascular Diseases; Cerebrovascular Disorders; Diabetes Mellitus; Environmental Monitoring; Environmental Pollutants; Epidemiological Monitoring; Female; Fetal Development; Fluorocarbons; Gonadal Steroid Hormones; Humans; Immune System; Kidney; Lipid Metabolism; Liver; Male; Reproduction; Uric Acid | 2010 |
11 other study(ies) available for caprylates and Cardiovascular Diseases
| Article | Year |
|---|---|
PFAS Concentrations and Cardiometabolic Traits in Highly Exposed Children and Adolescents.
Topics: Adolescent; Adult; Alkanesulfonic Acids; Caprylates; Cardiovascular Diseases; Child; Cross-Sectional Studies; Drinking Water; Environmental Pollutants; Fluorocarbons; Humans | 2021 |
Physical activity modifies the relation between gestational perfluorooctanoic acid exposure and adolescent cardiometabolic risk.
Topics: Adolescent; Alkanesulfonic Acids; Caprylates; Cardiovascular Diseases; Child; Environmental Pollutants; Exercise; Female; Fluorocarbons; Humans; Insulin Resistance; Pregnancy; Prospective Studies | 2022 |
Associations between serum perfluoroalkyl acid (PFAA) concentrations and health related biomarkers in firefighters.
Topics: Alkanesulfonates; Alkanesulfonic Acids; Australia; Biomarkers; Caprylates; Cardiovascular Diseases; Cholesterol; Cross-Sectional Studies; Environmental Pollutants; Firefighters; Fluorocarbons; Humans; Thyrotropin; Uric Acid | 2022 |
Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort.
Topics: Aged; Alzheimer Disease; Apolipoprotein E4; Caprylates; Cardiovascular Diseases; Cognitive Dysfunction; Female; Humans; Neuroimaging | 2023 |
Increased Cardiovascular Risk Associated with Chemical Sensitivity to Perfluoro-Octanoic Acid: Role of Impaired Platelet Aggregation.
Topics: Adult; Blood Platelets; Caprylates; Cardiovascular Diseases; Environmental Pollution; Fluorocarbons; Humans; Italy; Male; Platelet Aggregation; Platelet Function Tests; Risk Factors; Water Pollutants, Chemical; Young Adult | 2020 |
Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
Topics: Adolescent; Alkanesulfonates; Alkanesulfonic Acids; Caprylates; Cardiovascular Diseases; Child; Child, Preschool; Cohort Studies; Environmental Pollutants; Female; Fluorocarbons; Humans; Ohio; Pregnancy; Prenatal Exposure Delayed Effects | 2021 |
Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation.
Topics: Adult; Alkanesulfonic Acids; Biomarkers; Caprylates; Cardiovascular Diseases; DNA Methylation; Epigenesis, Genetic; Female; Fluorocarbons; Humans; Long Interspersed Nucleotide Elements; Male; Middle Aged; Risk Factors | 2014 |
Self-reported health effects among community residents exposed to perfluorooctanoate.
Topics: Adolescent; Adult; Aged; Caprylates; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Dose-Response Relationship, Drug; Environmental Exposure; Female; Fluorocarbons; Humans; Male; Middle Aged; Ohio; Prevalence; Respiratory Tract Diseases; Surveys and Questionnaires; Water Pollution, Chemical; West Virginia | 2008 |
Perfluorooctanoic acid and cardiovascular disease in US adults.
Topics: Adult; Caprylates; Cardiovascular Diseases; Environmental Exposure; Female; Fluorocarbons; Humans; Male; Prevalence; Risk Factors; United States | 2012 |
Perfluorooctanoic acid exposure and cardiovascular disease: potential role and preventive measures: comment on "Perfluorooctanoic acid and cardiovascular disease in US adults".
Topics: Caprylates; Cardiovascular Diseases; Environmental Exposure; Female; Fluorocarbons; Humans; Male | 2012 |
The effect of octanoic fatty acid on the cardiovascular system of the guinea pig.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Caprylates; Cardiac Output; Cardiovascular Diseases; Cardiovascular System; Dinoprostone; Guinea Pigs; Hepatic Encephalopathy; Humans; Indomethacin; Liver Cirrhosis; Male; Syndrome; Vascular Resistance | 1989 |